 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/11/2024 |
$3.49 |
$3.73 |
$3.49 |
$3.71 |
516.80K | | 04/12/2024 |
$3.69 |
$3.73 |
$3.48 |
$3.51 |
562.10K | | 04/15/2024 |
$3.51 |
$3.54 |
$3.28 |
$3.32 |
842.90K | | 04/16/2024 |
$3.28 |
$3.36 |
$3.23 |
$3.31 |
761.90K | | 04/17/2024 |
$3.32 |
$3.37 |
$3.17 |
$3.21 |
846.10K |
|
|
| Cellectar Biosciences is a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer. Co.'s phospholipid drug conjugate (PDC) therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells. Co.'s product pipeline also includes one preclinical PDC chemotherapeutic program (CLR 1900) and several partnered PDC assets. The CLR 1900 Series is being developed for solid tumors with a payload that inhibits mitosis a validated pathway for treating cancers. | |
|
Cellectar Biosciences (CLRB) has the following price history information. Looking back at CLRB historical stock prices for the last five trading days, on April 11, 2024, CLRB opened at $3.49, traded as high as $3.73 and as low as $3.49, and closed at $3.71. Trading volume was a total of 516.80K shares. On April 12, 2024, CLRB opened at $3.69, traded as high as $3.73 and as low as $3.48, and closed at $3.51. Trading volume was a total of 562.10K shares. On April 15, 2024, CLRB opened at $3.51, traded as high as $3.54 and as low as $3.28, and closed at $3.32. Trading volume was a total of 842.90K shares. On April 16, 2024, CLRB opened at $3.28, traded as high as $3.36 and as low as $3.23, and closed at $3.31. Trading volume was a total of 761.90K shares. On April 17, 2024, CLRB opened at $3.32, traded as high as $3.37 and as low as $3.17, and closed at $3.21. Trading volume was a total of 846.10K shares.
CLRB Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cellectar Biosciences shares, starting with a $10,000 purchase of CLRB, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/17/2024 |
|
| Start price/share: |
$360.00 |
|
| End price/share: |
$3.21 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.11% |
|
| Average Annual Total Return: |
-37.64% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$89.16 |
|
| Years: |
9.99 |
|
|
|
| Date |
Close |
| 04/11/2024 | $3.71 | | 04/12/2024 | $3.51 | | 04/15/2024 | $3.32 | | 04/16/2024 | $3.31 | | 04/17/2024 | $3.21 |
|
|
Free CLRB Email Alerts:
